Canada-based Aurora Cannabis (NASDAQ: ACB) has been on a downward spiral for the past few years. Industry headwinds, as well as some of Aurora's own actions, dragged the stock down, causing investors to lose faith in the company.

Aurora has left no stone unturned to achieve positive earnings before interest, taxes, depreciation, and amortization (EBITDA). Despite cutting costs by shutting underperforming facilities and making acquisitions in a bid for growth, it failed time and again to hit its target. However, its most recent quarterly results came as a big surprise. Let's look at both the positive and negative aspects of investing in Aurora's stock right now.

Image source: Getty Images.

Continue reading

Source Fool.com